The Chief Executive Officer (CEO) of the Malaria Consortium, Dr. James Tibenderana, has revealed that not less than 97 per cent of Nigerians are at risk of contracting malaria.
Noting that every state in the country is at risk, Tibenderana stressed that even with the deployment of interventions like insecticide-treated nets, indoor residual spraying, testing, and rapid diagnostic tests, Nigeria is still not achieving optimal coverage of these tools.
While stating that the expected malaria vaccine would help reduce the prevalence, he urged Nigerians to make use of the insecticide-treated mosquito nets.
Lafiya360 reports that the Malaria Consortium is a non-profit organization established in 2003 with a mandate on maternal and child health, using malaria as an entry point to bring technical and managerial support to the health system in Asia and Africa. It began operations in Nigeria in 2008 and has reached a vulnerable population of mainly women and children with prevention and treatment of malaria and other communicable diseases in Nigeria, covering 22 states and the FCT at different times.
Speaking during a press conference in Abuja to commemorate its 20 years of service to world health, Tibenderana said, “Every single state in Nigeria is at risk of malaria. 97 per cent of the population is at risk of malaria. It is also important to appreciate that with the next interventions that are being deployed, such as insecticide-treated nets, indoor residual spraying, testing, and rapid diagnostic tests we are getting the right treatment. However, we are not achieving optimal coverage of these tools.
“It is important that we understand that the mosquito or the parasites do not remain the same. They respond to what is going on in their environment. One of the things we need to get better at is that as a global community, we have to adapt to the changes that are taking place in the mosquito, as well as the parasite.
“So we must have the next generation of new drugs, the next generation of insecticides and the next generation of nets. We also need to add to the pipeline the next generation of vaccines, so that as the mosquito and the parasite are changing, we have new tools to deploy.
“The two vaccines that have been recommended by the World Health Organisation were on the basis that nets are being used and that households have access to treatments whenever they have a fever. We don’t yet have a vaccine that works on its own and that type of vaccine is still a long way off.
“So, none of the tools that we are deploying work alone, they work in combination. Sometimes they are synergistic. In other words, the combined effect is greater than if you deploy them singly. So, for Nigeria to derive the optimal impact of these interventions, coverage needs to be high, use needs to be consistent and we all need to be involved in this struggle to free Nigeria from malaria.”
In his remarks, the Country Director of the Malaria Consortium in Nigeria, Dr. Kolawole Maxwell, stated that the organisation has secured $200 million for ongoing malaria projects in Nigeria from 2020 to 2026. He explained that $250 million of the amount has been spent on training, procurement of commodities, and net distribution to Nigerians. “So, indeed, this is 20 years of celebration of good partnership, prevention of Nigerian children from dying, working with the government, and partners,” he said.
According to reports from the World Health Organization (WHO), Nigeria accounts for around 27 per cent of the global burden of malaria cases. Also, malaria incidence in the country has fallen by 26 per cent since 2000, from 413 per 1000 to 302 per 1000 in 2021, and malaria deaths fell by 55 per cent, from 2.1 per 1000 population to 0.9 per 1000 population.